ETFChannel.com
SLIDESHOW: 10 ETFs With Most Upside To Analyst Targets
By ETF Channel Staff, updated Tue, January 19, 11:35 PM
| This Slide: #1 of 10 |
Pharmaceutical ETF (NASDAQ:PPH)
Recent PPH price: $69.72, Implied analyst target: $77.76 — 11.53% Upside
Based upon our analysis of the average analyst target prices for the underlying holdings of PPH versus the current trading prices of those same holdings, the weighted combined analyst target price for the ETF itself works out to $77.76, which implies that analysts see 11.53% upside to the ETF based upon their view of the underlying holdings.
Open the PPH Page at ETF Channel to see the underlying holdings »
|
||||||||||||||||||||||||||||||||||
Open the ETF Channel PPH Page (in a new window) »
PPH Average Broker Rec.
 
|
Buy (3.13 out of 4) 100th percentile
(ranked higher than approx. 100% of all stocks covered)
Based on data provided by Zacks Investment Research via Quandl.com |
|
|
| Avg. Broker Rec.
|
Buy (3.13 out of 4) 25th percentile
(ranked lower than approx. 75% of all etfs covered)
Based on data provided by Zacks Investment Research via Quandl.com |
|
|
